Carlsmed Inc. is marking the first personalized cervical plating procedure using the corra Cervical Plating System, the latest addition to its personalized spine surgery solutions portfolio.

Performed by Dr. Aaron Clark at the University of California San Francisco (UCSF), corra’s clinical debut occurs as the company prepares to commercially launch the product later this year.

“We’re excited to expand our personalized cervical offerings following the recent launch of our aprevo Cervical Interbody System,” Carlsmed Chairman/CEO Mike Cordonnier said. “This first procedure and the commencement of the clinical evaluation is an important step in validating our technology in a real-world setting. We developed corra to address unmet needs in cervical spine surgery, and we remain committed to delivering solutions designed to support surgeons, improve alignment precision and enhance patient outcomes through truly personalized design.”

The corra Cervical Plating System is designed to stabilize the cervical spine during fusion procedures using patient-specific plates tailored to each individual’s anatomy and surgical plan. Utilizing Carlsmed’s digital surgery ecosystem, key anatomical aspects including screw positioning and plate curvature are tailored pre-operatively to each vertebral level, helping support consistent fixation and precise alignment for Anterior Cervical Discectomy and Fusion (ACDF) procedures. When used with the aprevo cervical planning and interbody fusion devices, the corra Personalized Plating System can provide anatomical fit and fixation for patients.

“Cervical plates play a critical role in stabilizing fusion constructs, and extending personalization to cervical fixation can enable more precise plate positioning and screw trajectory,” Dr. Clark stated. “Designing each plate around patient-specific anatomy and alignment objectives has the potential to reduce intraoperative contouring and support more accurate execution of the preoperative plan. This precision reinforces confidence in the biomechanics of each patient’s construct and may help mitigate risks associated with adjacent-level stress that can contribute to postoperative symptoms and revision surgery following ACDF procedures.”

Data from the clinical evaluation will inform continued product refinement as Carlsmed prepares for broader market introduction. The company expects to conduct additional evaluations in the coming months and will likely introduce the product to market later this year.

Carlsmed is a medical technology company pioneering artificial intellligence (AI)-enabled personalized spine surgery solutions that help improve outcomes and decrease healthcare costs for spine surgery and beyond.